GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 3376 - 3400 of 4050 in total
Antibody Patient Onset (days) Symptom GlyTouCan ID Arbitrary Fluorescence Units (AFU) ▼
IgG Patient 3 -180 mild
G57449OF
44
IgG Patient 3 -180 mild
G58969RU
44
IgG Patient 3 -180 mild
G72424VO
44
IgG Patient 3 11 mild
G00065MO
44
IgG Patient 3 11 mild
G19868AX
44
IgG Patient 3 11 mild
G38488WF
44
IgG Patient 3 11 mild
G40696TO
44
IgG Patient 3 11 mild
G53168IY
44
IgG Patient 3 11 mild
G82942ZJ
44
IgG Patient 3 4 mild
G09609EN
44
IgG Patient 3 4 mild
G18057VI
44
IgG Patient 3 4 mild
G25473LQ
44
IgG Patient 3 4 mild
G28868ZC
44
IgG Patient 1 10 moderate
G47566FL
43
IgG Patient 1 22 moderate
G54064FW
43
IgG Patient 1 22 moderate
G82348BZ
43
IgM Patient 1 10 moderate
G73271MD
43
IgG Patient 1 6 moderate
G62222PE
43
IgG Patient 1 6 moderate
G68703KI
43
IgM Patient 1 6 moderate
G02670IJ
43
IgM Patient 1 6 moderate
G24617OK
43
IgM Patient 1 6 moderate
G89993FE
43
IgG Patient 2 15 mild
G29011JC
43
IgM Patient 2 24 mild
G12200GB
43
IgG Patient 2 3 mild
G08520NM
43

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024